Top
OR2G3 has not been detected as a mutational cancer driver

OR2G3
Ensembl id ENSG00000177476
Mutated samples
Coding Sequence 96 (1.4%)
Protein Affecting 66 (1.0%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all OR2G3 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 39 23 6.23
Lung adenocarcinoma No 12 10 2.56
Lung squamous cell carcinoma No 12 9 5.17
Breast carcinoma No 8 6 0.52
Stomach adenocarcinoma No 8 6 3.73
Small cell lung carcinoma No 3 3 4.35
Bladder carcinoma No 2 2 2.04
Uterine corpus endometrioid carcinoma No 2 2 0.87
Esophageal carcinoma No 2 2 1.37
Non small cell lung carcinoma No 1 1 3.23
Head and neck squamous cell carcinoma No 3 1 0.27
Glioblastoma multiforme No 1 1 0.26
Thyroid carcinoma No 1 0 0.00
Chronic lymphocytic leukemia No 1 0 0.00
Lower grade glioma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence